Gianfranco Percario

Suggest Changes
Learn More
BACKGROUND There is yet no established treatment for chronic hepatitis C patients non-responder to standard interferon and ribavirin. AIM To evaluate efficacy and safety of(More)
BACKGROUND Between 350 and 400 million people worldwide have chronic hepatitis B virus (HBV) infection, and in Italy this figure is 1% to 2% in the general population. In clinical practice, however,(More)